---
title: Practical solutions for including Sex As a Biological Variable (SABV) in preclinical
  neuropsychopharmacological research
date: '2023-11-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37918446/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231103180959&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Recently, many funding agencies have released guidelines on the importance
  of considering sex as a biological variable (SABV) as an experimental factor, aiming
  to address sex differences and avoid possible sex biases to enhance the reproducibility
  and translational relevance of preclinical research. In neuroscience and pharmacology,
  the female sex is often omitted from experimental designs, with researchers generalizing
  male-driven outcomes to both sexes, risking a biased or ...
disable_comments: true
---
Recently, many funding agencies have released guidelines on the importance of considering sex as a biological variable (SABV) as an experimental factor, aiming to address sex differences and avoid possible sex biases to enhance the reproducibility and translational relevance of preclinical research. In neuroscience and pharmacology, the female sex is often omitted from experimental designs, with researchers generalizing male-driven outcomes to both sexes, risking a biased or ...